Lonza Group Ltd ADR LZAGY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $75.31
- Day Range
- $76.20–76.85
- 52-Week Range
- $58.53–76.85
- Bid/Ask
- $51.41 / $84.18
- Shares Outstanding
- 698.44M
- Market Cap
- $53.56B
- Volume/Avg
- 123,266 / 39,581
Key Statistics
- Price/Earnings (Normalized)
- 36.55
- Price/Sales
- 6.62
- Dividend Yield (Trailing)
- 0.84%
- Dividend Yield (Forward)
- 0.84%
- Dividend Payment Schedule
- Jun
- Total Yield
- 1.28%
Company Profile
Lonza Group is a leading contract development and manufacturing organization operating through three main segments: integrated biologics, advanced synthesis, and specialized modalities. It generates revenue primarily through long-term supply agreements with biopharmaceutical customers. The company provides comprehensive services spanning the entire product lifecycle, from early-stage drug development to large-scale commercial supply. Its diverse client base includes global pharmaceutical and biotechnology companies, academic institutions, and research organizations.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Growth
- Total Number of Employees
- 20,141
- Website
- https://www.lonza.com
Competitors
Valuation
|
Metric
|
LZAGY
|
02269
|
SFZN
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.55 | 28.74 | 18.69 |
Price/Book Value | 5.23 | 3.52 | 3.20 |
Price/Sales | 6.62 | 7.16 | 2.37 |
Price/Cash Flow | 21.36 | 19.44 | 13.42 |
Price/Earnings
LZAGY
02269
SFZN
Financial Strength
|
Metric
|
LZAGY
|
02269
|
SFZN
|
|---|---|---|---|
Quick Ratio | 0.59 | 2.64 | 1.36 |
Current Ratio | 1.66 | 3.32 | 3.45 |
Interest Coverage | 9.29 | 67.52 | 24.55 |
Quick Ratio
LZAGY
02269
SFZN
Profitability
|
Metric
|
LZAGY
|
02269
|
SFZN
|
|---|---|---|---|
Return on Assets (Normalized) | 6.27% | 10.38% | 7.56% |
Return on Equity (Normalized) | 13.97% | 14.65% | 15.73% |
Return on Invested Capital (Normalized) | 9.75% | 11.25% | 10.10% |
Return on Assets
LZAGY
02269
SFZN
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|vWvp>&d | LOCK|sKf | $257B | |||
| Danaher Corp
DHR
| LOCK|x#tCZV#q | LOCK|q%Z | $164B | |||
| Agilent Technologies Inc
A
| LOCK|GZ%<CX$ | LOCK|B! | $50B | |||
| IQVIA Holdings Inc
IQV
| LOCK|Z$!qt#< | LOCK|B>@@ | $46B | |||
| Waters Corp
WAT
| LOCK|$@?<rk& | LOCK|#! | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|!#<@y!q | LOCK|J$d | $44B | |||
| Illumina Inc
ILMN
| LOCK|hBfKhh% | LOCK|?>V> | $43B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|&tH?K!T | LOCK|^w>b? | $34B | |||
| Quest Diagnostics Inc
DGX
| LOCK|%mm^H$> | LOCK|>m$#s | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|#><l@@mz | LOCK|VQ#R | $26B |
United States